The Clearance of Human Cytomegalovirus Using CRISPR/Cas9 RNA Lipid Nanoparticles
Lau, Y. M. A.; Pang, J.; Jiang, M. Q.; Sun, Y.; Knaggs, K. L. M.; Tilstra, G.; Oproescu, A.-M.; Couture-Senecal, J.; Manning, A. M.; Maaieh, R.; Ferreira, V. H.; Humar, A.; Khan, O. F.
Show abstract
Human cytomegalovirus (HCMV), a DNA virus, poses significant health risks to immunocompromised and immunosuppressed individuals and newborns. Clinical antiviral drugs like ganciclovir inhibit viral replication but have toxicities, are ineffective against drug-resistant strains, and cannot destroy HCMV DNA. CRISPR/Cas9 can cleave DNA, but has not been used therapeutically to target and degrade HCMV DNA in cells post-infection. We developed an all-in-one CRISPR/Cas9 RNA lipid nanoparticle (LNP) that clears established HCMV infections, permits rapid updating to combat resistance and is effective against multiple strains. Bioinformatic analyses identified essential, conserved viral genes as CRISPR/Cas9 targets. A delivery material screen revealed that antiviral activity was dependent on the ionizable lipid and LNP composition. Our lead formulation, {beta}N2-40, inhibited up to 93.5% of HCMV infection with a single treatment. Furthermore, multitargeting {beta}N2-40 LNPs demonstrated antiviral kinetics and a safety profile similar to ganciclovir, making it a compelling alternative to existing small-molecule antiviral drugs.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance 96%
- An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants 96%
- Engineering self-deliverable ribonucleoproteins for genome editing in the brain 95%
Similar papers in this journal
- Alphaviral capsid proteins inhibit stress granule assembly via competitive RNA binding with G3BP1 94%
- TSHR-targeting nucleic acid aptamer treats Graves' ophthalmopathy via novel allosteric inhibition 94%
- ProT-Diff: A Modularized and Efficient Approach to De Novo Generation of Antimicrobial Peptide Sequences through Integration of Protein Language Model and Diffusion Model 93%
Similar papers in this journal
- Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies 95%
- Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses 94%
- Elucidating the Mechanism by Which HIV-1 Nucleocapsid Mutations Confer Resistance to Integrase Strand Transfer Inhibitors 94%
Similar papers in this journal
- CRISPRCas9-mediated gene disruption of endogenous co-receptors confers broad resistance to HIV-1 in human primary cells and humanized mice 94%
- Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment 94%
- Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient And Long-Term Transgene Expression In The Central Nervous System 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.